Cargando...
Antiresorptive agents' bone‐protective and adjuvant effects in postmenopausal women with early breast cancer
Potent antiresorptive drugs (bisphosphonate and denosumab) are often used to protect bone health in postmenopausal breast cancer patients. In addition, clinical trials have shown that these drugs increase disease‐free survival, though the mechanism of adjuvant benefit is largely unknown. Here we rev...
Guardado en:
| Publicado en: | Br J Clin Pharmacol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533425/ https://ncbi.nlm.nih.gov/pubmed/30536446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13834 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|